MR-linac: role of artificial intelligence and automation

Serena Psoroulas1, Alina Paunoiu1, Stefanie Corradini2

  • 1Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Summary

Artificial intelligence (AI) is revolutionizing radiotherapy by automating tasks like organ delineation and treatment planning. This enhances efficiency and accuracy, particularly with advanced technologies like magnetic resonance (MR)-guided linear accelerators (MR-linacs).